FUJIFILM has invested about $4 billion in building biopharmaceutical manufacturing sites and life sciences capabilities.

Pelthos Therapeutics, a Durham-based wholly owned subsidiary of Ligand Pharmaceuticals (Nasdaq: LGND), is combining with ...

Japan’s Nikkei hit a three-week closing high on Wednesday as a strong rebound in Wall Street prompted investors to scoop up ...

FujiFilm Diosynth plans to produce Regeneron's biologic medicines over 10 years in its Holly Springs facility, which is scheduled to begin operations this year.

Ahead of its scheduled opening later this year, the massive Fujifilm Diosynth Biotechnologies manufacturing plant in Holly ...

Holly Springs, North Carolina Wednesday, April 23, 2025, 14:00 Hrs [IST] ...

Japan's Nikkei hit a three-week closing high on Wednesday as a strong rebound in Wall Street prompted investors to scoop up ...

TOKYO: Japan’s Nikkei share average climbed to a three-week high on Wednesday as a strong rebound in Wall Street prompted ...

Agreement secures additional U.S. manufacturing capacity to help ensure patient access to medicineHOLLY SPRINGS, N.C., April 23, 2025 -- ...

Roche projected that its $50 billion manufacturing investment, to include R&D operations, will generate 1,000 jobs at the ...

Karoline Leavitt leaves briefing after tough questions on Trump's Iran stance and Russia-Ukraine conflict. Tensions rise ...

FUJIFILM Diosynth Biotechnologies, a global contract development and manufacturing organization (CDMO) with major operations ...